TrialThe New England journal of medicine2021

Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency.

Donald B Kohn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.